Assignee
SHENZHEN FORWARD PHARMACEUTICALS CO LTD
CN·1 granted patent·6 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
7 records- 0150US2024391902A1Crystalline Form of CompoundSHENZHEN FORWARD PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0250US2023234941A1Salts of Compound and Pharmaceutical Compositions Containing the SameSHENZHEN FORWARD PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0344US2025154156A1Quinazoline derivative as kras g12c mutation inhibitorSHENZHEN FORWARD PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0443US2025277041A1Anti-fgfr2 adcc enhanced antibody and use thereofSHENZHEN FORWARD PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0542US12258344B2Azaaromatic amide derivatives for the treatment of cancerSHENZHEN FORWARD PHARMACEUTICALS CO LTD·Filed 2020·Granted Mar 25, 2025·0 cites·8 claims
- 0638US2024101683A1Anti-FGFR2 Antibody and Use ThereofSHENZHEN FORWARD PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0736US2024217988A1Estrogen receptor antagonistSHENZHEN FORWARD PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN FORWARD PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →